Palatin Technologies Competitors and Similar CompaniesClear all
Palatin Technologies's competitors and similar companies include CalciMedica, DiscGenics, Antiva Biosciences and Curza.
 Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. |  CalciMedica CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors. |  DiscGenics DiscGenics is a biopharmaceutical company focused on developing regenerative therapies for patients with diseases of the spine. |  Antiva Biosciences Antiva Biosciences is a biopharmaceutical company which develops therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection. |  Curza Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology. | |
Founding Date | Founding Date 1986 | Founding Date 2007 | Founding Date 2007 | Founding Date 2012 | Founding Date 2021 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations East Windsor, US HQ | Locations La Jolla, US HQ | Locations Salt Lake City, US HQ Salt Lake City, US | Locations South San Francisco, US HQ Redwood City, US | Locations Salt Lake City, US HQ |
Employees | Employees 185% decrease | Employees 1614% increase | Employees 363% decrease | Employees N/A | Employees 186% increase |
Valuation ($) | Valuation ($) 22.5 m | Valuation ($) 42.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($17.3m) (FY, 2025) | Net income ($29.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 50m (almost 6 years ago) | Latest funding round $ 15m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 104.2m | Total funding raised $ 74.5m | Total funding raised $ 68m | Total funding raised $ 56.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CalciMedica
HQ
La Jolla, US
Employees
16↑ 14% increase
CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors.
View companyDiscGenics
HQ
Salt Lake City, US
Employees
36↓ 3% decrease
DiscGenics is a biopharmaceutical company focused on developing regenerative therapies for patients with diseases of the spine.
View companyAntiva Biosciences
HQ
South San Francisco, US
Antiva Biosciences is a biopharmaceutical company which develops therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection.
View companyCurza
HQ
Salt Lake City, US
Employees
18↑ 6% increase
Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology.
View company